Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
2.470
+0.050 (2.07%)
At close: Sep 24, 2025, 4:00 PM EDT
2.550
+0.080 (3.24%)
After-hours: Sep 24, 2025, 7:52 PM EDT
Cabaletta Bio Market Cap
Cabaletta Bio has a market cap or net worth of $225.92 million as of September 24, 2025. Its market cap has increased by 8.57% in one year.
Market Cap
225.92M
Enterprise Value
56.13M
1-Year Change
8.57%
Ranking
Category
Stock Price
$2.47
Market Cap Chart
Since October 25, 2019, Cabaletta Bio's market cap has decreased from $235.53M to $225.92M, a decrease of -4.08%. That is a compound annual growth rate of -0.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2025 | 221.35M | 99.50% |
| Dec 31, 2024 | 110.95M | -88.59% |
| Dec 29, 2023 | 972.68M | 260.85% |
| Dec 30, 2022 | 269.55M | 151.03% |
| Dec 31, 2021 | 107.38M | -64.23% |
| Dec 31, 2020 | 300.21M | -10.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 669.55B |
| Johnson & Johnson | 424.76B |
| AbbVie | 393.38B |
| UnitedHealth Group | 315.24B |
| Novo Nordisk | 268.59B |
| Novartis AG | 238.07B |
| Abbott Laboratories | 236.37B |
| AstraZeneca | 235.93B |